Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Johnson & Johnson (NYSE:JNJ)

119.52
Delayed Data
As of Feb 22
 -0.14 / -0.12%
Today’s Change
102.97
Today|||52-Week Range
126.07
+3.74%
Year-to-Date
JNJ Regular Dividend: JNJ will begin trading ex-dividend on 02/24/17 with a $0.80 dividend payable to shareholders of record as of 02/28/17.
Cramer: Buyers for Bristol-Myers Are Few and Far Between
Feb 22 / TheStreet.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Merck, Valeant Pharmaceuticals International, Alle...
Feb 21 / Zacks.com - Paid Partner Content
These 10 stocks dominate the market
Feb 22 / CNNMoney.com
3 Stocks to Invest in Big Pharma
Feb 20 / MotleyFool.com - Paid Partner Content
3 Dividend Stocks for 2017
Feb 21 / GuruFocus News - Paid Partner Content
Better Buy: Eli Lilly and Company vs. Johnson & Johnson
Feb 18 / MotleyFool.com - Paid Partner Content
Takeaways and Observations
Feb 21 / TheStreet.com - Paid Partner Content
The Four Key Themes From Q4 Conference Calls
Feb 17 / Investing Channel - Paid Partner Content
Bristol-Myers Buys Back Shares, Shuffles Board
Feb 21 / TheStreet.com - Paid Partner Content
Geron (GERN) Q4 Earnings: What's in Store for the Stock?
Feb 17 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close119.66
Today’s open119.28
Day’s range119.25 - 119.77
Volume5,103,903
Average volume (3 months)7,192,883
Market cap$325.5B
Dividend yield2.68%
Data as of 4:01pm ET, 02/22/2017

Growth & Valuation

Earnings growth (last year)+8.21%
Earnings growth (this year)+4.73%
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)+2.41%
P/E ratio21.0
Price/Sales4.47
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PFEPfizer-0.03-0.09%
MRKMerck-0.19-0.29%
NVSNovartis-0.19-0.25%
SNYSanofi-0.24-0.56%
Data as of 4:02pm ET, 02/22/2017

Financials

Next reporting dateApril 18, 2017
EPS forecast (this quarter)$1.76
Annual revenue (last year)$71.9B
Annual profit (last year)$16.5B
Net profit margin23.01%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Alex Gorsky
Chief Financial Officer &
Vice President
Dominic J. Caruso
Corporate headquarters
New Brunswick, New Jersey

Forecasts


Search for Jobs